The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback